Valuation: Uscom Limited

Market Cap 3.12M 2.18M 1.93M 1.81M 1.64M 3.1M 210M 21.75M 8.46M 107M 8.18M 8.01M 345M P/E 2024
-1.25x
P/E 2025 -0.88x
Enterprise Value 4.42M 3.09M 2.74M 2.56M 2.32M 4.39M 297M 30.78M 11.97M 152M 11.58M 11.33M 488M EV / Sales 2024
0.57x
EV / Sales 2025 2.06x
Free-Float
17.04%
Yield 2024 *
-
Yield 2025 -
3 years 0.01
Extreme 0.011
0.05
5 years 0.01
Extreme 0.011
0.14
10 years 0.01
Extreme 0.011
0.53
Manager TitleAgeSince
Chief Executive Officer - 07/03/2011
Corporate Secretary 66 24/05/2016
Corporate Officer/Principal - 28/05/2018
Director TitleAgeSince
Chairman - 01/11/2009
Director/Board Member 66 23/08/2018
Director/Board Member 62 16/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
+9.09%-.--%-.--%-76.00% 2.18M
-2.22%-2.46%+21.87%+32.97% 250B
-1.87%-3.83%+2.71%+0.10% 156B
-0.12%-1.68%-9.88%+37.06% 144B
-0.48%-3.91%-56.40%-19.10% 61.45B
-0.80%-1.68%+13.11%+17.50% 50.28B
+1.66%-1.50%-21.21%-19.75% 46.73B
-0.74%-3.03%+19.86%+53.41% 48.29B
+0.04%+2.03%-5.18%+35.61% 45.89B
-0.90%-1.37%+33.45%+63.50% 43.24B
Average +0.35%-2.09%-0.17%+12.53% 84.52B
Weighted average by Cap. -1.11%-2.77%+3.37%+22.87%

Financials

2024 2025
Net sales 3.73M 2.6M 2.31M 2.16M 1.96M 3.7M 251M 25.96M 10.1M 128M 9.77M 9.56M 411M 2.58M 1.8M 1.6M 1.5M 1.36M 2.56M 174M 17.96M 6.99M 88.54M 6.76M 6.61M 285M
Net income -2.07M -1.45M -1.29M -1.2M -1.09M -2.06M -140M -14.45M -5.62M -71.23M -5.44M -5.32M -229M -3.3M -2.31M -2.05M -1.92M -1.74M -3.28M -222M -23.01M -8.95M -113M -8.66M -8.47M -365M
Net Debt -1.53M -1.07M -949K -888K -805K -1.52M -103M -10.66M -4.15M -52.55M -4.01M -3.93M -169M 1.3M 906K 804K 752K 682K 1.29M 87.3M 9.04M 3.51M 44.54M 3.4M 3.33M 143M
Projected Income Statement - Annual - Uscom Limited
Logo Uscom Limited
Uscom Limited is an Australia-based medical technology company specializing in development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company offers three suites of devices in the field of cardiac, vascular and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, the Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms at the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. The Uscom SpiroSonic digital ultrasonic spirometers are high fidelity, digital, pulmonary function testing devices based on multi-path ultrasound technology.
Employees
35